Clenbuterol - regional food contamination a possible source for inadvertent doping in sports

Drug Testing and Analysis

Volumn 4, Issue 6, 2012, Pages 534-538

  Guddat, S ^a   Fussholler G ^a   Geyer, H ^a   Thomas, A ^a   Braun, H ^a   Haenelt, N ^a   Schwenke, A ^a   Klose, C ^a   Thevis, M ^a   Schanzer W ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Clenbuterol; Food contamination; Inadvertent doping; LC MS MS; Sports drug testing

Indexed keywords

AGRICULTURE; BODY FLUIDS; CONTAMINATION; FOOD SAFETY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ANABOLIC AGENTS; CLENBUTEROL; DRUG TESTING; FOOD CONTAMINATION; INADVERTENT DOPING; LC-MS-MS; LC.MS/MS; SPORT DRUG TESTING; SYMPATHOMIMETIC AGENTS; URINE SAMPLE;

SPORTS;

CLENBUTEROL;

ACCURACY; ADULT; ARTICLE; ATHLETE; CHINA; CONTROLLED STUDY; DOPING; DRUG DETERMINATION; DRUG LEGISLATION; DRUG MISUSE; FEMALE; FOOD CONTAMINATION; HUMAN; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MEAT; PRIORITY JOURNAL; SPORT; TANDEM MASS SPECTROMETRY; URINALYSIS; VOLUNTEER;

EID: 84863110299     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1330     Document Type: Article

References (18)

1. K. H. Kim, Y. S. Kim, J. Yang. The muscle-hypertrophic effect of clenbuterol is additive to the hypertrophic effect of myostatin suppression. Muscle Nerve 2011, 43, 700.
2. Y. S. Kim, R. D. Sainz. β-adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 1992, 50, 397.
3. H. A. Kuiper, M. Y. Noordam, M. M. van Dooren-Flipsen, R. Schilt, A. H. Roos. Illegal use of beta-adrenergic agonists: European Community. J. Anim. Sci. 1998, 76, 195.
4. BgVV. Rückstandskontrollen bei Schlachttieren und Fleisch belegen die fortwährende illegale Anwendung bestimmter Substanzen, Pressemitteilung, Bundesinstitut für Verbraucherschutz und Veterinärmedizin. Available at: [3 November 2011].
5. G. Luk. Leanness-enhancing Agents in Pork, in Food Safety Focus, Veterinary Public Health Section, Centre for Food Safety, Hong Kong. Available at: [2 November 2011].
6. CNN. Available at: [3 November 2011].
7. Eworldpost. Available at: [2 November 2011].
8. M. C. Estrada-Montoya, A. F. González-Córdova, G. Torrescano, J. P. Camou, B. Vallejo-Cordoba. Screening and confirmatory determination of clenbuterol residues in bovine meat marketed in the northwest of Mexico. Ciencia y Tecnología Alimentaria 2008, 6, 130.
9. MEXICO: Confirmed outbreak of poisoning by clenbuterol. Available at: [3 November 2011].
10. P. Hemmersbach, S. Tomten, S. Nilsson, H. Ofterbo, O. Havrevoll, B. Oen, et al. Illegal use of anabolic agents in animal fattening - Consequences for doping analysis, in Recent Advances in Doping Analysis (2), Sport und Buch Strauß, Köln, 1995, pp. 185-191.
11. WADA. 2010 Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories. Available at: [3 November 2011].
12. M. Thevis, T. Schebalkin, A. Thomas, W. Schanzer. Quantification of clenbuterol in human plasma and urine by liquid chromatography-tandem mass spectrometry. Chromatographia 2005, 62, 435.
13. WADA. International Standard for Laboratories v 6.0. Available at: [3 November 2011].
14. ICH. Validation of analytical procedures: Text and methodology Q2 (R1) (2), in International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at: [3 November 2011].
15. T. M. Annesley. Ion suppression in mass spectrometry. Clin. Chem. 2003, 49, 1041.
16. BVL, B. f. V. u. L. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Tabellen der Ergebnisse des Nationalen Rückstandskontrollplans 2009. Available at: [3 November 2011].
17. I. Yamamoto, K. Iwata, M. Nakashima. Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit. J Pharmacobio-dynam. 1985, 8, 385.
18. J. Pleadin, A. Vulic, N. Persi, N. Vahcic. Clenbuterol residues in pig muscle after repeat administration in a growth-promoting dose. Meat Sci. 2010, 86, 733.